StockData
Teradyne, Inc logo

Teradyne, Inc (TER) stock analysis

TERNasdaqInstruments For Meas & Testing of Electricity & Elec SignalsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 27, 2026Last filing: 10-Q on Oct 30, 2026Score 21/307% below fair value
$265.78+20.38 (+8.30%)

Close on Nov 11, 2026Market cap $41.49BP/E 30.5Yield 0.18%

StockData Score

Prices as of Nov 11, 2026How the score works

Value4Growth3Performance5Health6Dividend3

Solid21 of 30 checks passed

Teradyne passes 21 of the 30 checks behind our score; 1 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.

Valuation
4/6
Growth
3/6
Past performance
5/6
Financial health
6/6
Dividend
3/6

What stands out

  • Trading below fair value

    The share price of $265.78 is below our fair value estimate of $284.52.

  • Return on equity over 15%

    Return on equity was 42.9% over the last twelve months and averaged 25.8% over five years.

  • Return on capital over 10%

    Return on invested capital was 47.3%, above the 10% that usually covers the cost of capital.

  • No debt

    Teradyne has no borrowings on its latest balance sheet.

What to watch

  • Margin of safety under 20%

    The price is 6.6% below fair value, less than the 20% cushion we look for.

  • Earnings shrank over 5 years

    Net income shrank 6.7% a year on average over the last five fiscal years.

  • Revenue growing under 10% a year

    Revenue grew 0.4% a year over the last three fiscal years, short of the 10% we look for.

  • EPS growing under 10% a year

    Diluted EPS grew -6.3% a year over the last three fiscal years.

Valuation4/6
  • P/E below its 5-year median

    Teradyne's P/E of 30.5 is below its own 5-year median of 30.9.

  • P/E below the industry

    Teradyne's P/E of 30.5 is below the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of 36.5.

  • EV/EBITDA below its 5-year median

    Teradyne's EV/EBITDA of 23.5 is below its 5-year median of 24.8.

  • P/B above the industry

    Teradyne's price-to-book of 11.25 is above the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of 3.17.

  • Trading below fair value

    The share price of $265.78 is below our fair value estimate of $284.52.

  • Margin of safety under 20%

    The price is 6.6% below fair value, less than the 20% cushion we look for.

Growth3/6
  • Revenue growing under 10% a year

    Revenue grew 0.4% a year over the last three fiscal years, short of the 10% we look for.

  • EPS growing under 10% a year

    Diluted EPS grew -6.3% a year over the last three fiscal years.

  • Earnings growth accelerating

    Net income grew 210% over the last twelve months, against a 5-year average of -6.7% a year.

  • Growing faster than the industry

    Revenue grew 74.9% over the last twelve months; the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median is 8.4%.

  • Guidance issued

    The latest outlook (fourth quarter of 2026 revenue, Oct 28, 2026) was issued for the first time, so it neither adds nor takes away points.

  • Gross margin improving

    Gross margin was 59.3% over the last twelve months, against 58.9% a year earlier.

Past performance5/6
  • Return on equity over 15%

    Return on equity was 42.9% over the last twelve months and averaged 25.8% over five years.

  • Return on capital over 10%

    Return on invested capital was 47.3%, above the 10% that usually covers the cost of capital.

  • Return on equity above the industry

    Teradyne's return on equity of 42.9% is above the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of 1.1%.

  • Earnings shrank over 5 years

    Net income shrank 6.7% a year on average over the last five fiscal years.

  • Net margin above its 5-year average

    Net margin was 27.5% over the last twelve months, against a 5-year average of 20.7%.

  • Net margin above the industry

    Teradyne's net margin of 27.5% is above the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of -1.3%.

Financial health6/6
  • No debt

    Teradyne has no borrowings on its latest balance sheet.

  • Debt not rising

    With no debt today, leverage cannot have risen.

  • Debt covered by cash flow

    There is no debt to cover.

  • Interest well covered

    Operating income covers interest expense 147.1 times.

  • Short-term assets cover short-term debts

    Current assets are 2.08 times current liabilities.

  • Low bankruptcy risk

    The Altman Z-score is 17.17; above 3 is the safe zone and below 1.8 the distress zone.

Dividend3/6
  • Pays a dividend

    Teradyne paid dividends worth 0.2% of the share price over the last twelve months.

  • Yield below Treasuries

    The 0.2% yield is below the 4.4% on a 1-year Treasury.

  • Yield below the top quarter

    The top quarter of US dividend payers yield 3.8% or more; Teradyne yields 0.2%.

  • Dividend was cut

    The dividend per share fell by more than 10% at least once in the last 10 fiscal years.

  • Covered by earnings

    Dividends take 5.8% of net income.

  • Covered by free cash flow

    Dividends take 7.8% of free cash flow.

Scores of similar companies

Our estimate per share

$284.52

The share price is 7% below this estimate.

20%+ below
Near fair value
20%+ above
$265.78Price
MethodMultiple usedOwn 5Y medianIndustry medianValue per shareWeight
P/E33.7×30.9×36.5×$293.4253%
EV/EBITDA24.3×24.8×23.7×$274.3647%
Earnings powerleft out, too far from the others13.4% cost of equity––$25.05–
Fair value$284.52100%

Valuation over time

Using the earnings and balance sheet published at each date, not today's.

  • P/E at month end
  • Own 5-year median 30.9
  • Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median 36.5

An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.

Market risk

From the past year of daily prices.

Liquidity

Low risk

Average value traded per day
$1.20B
Value traded per 1% price move
$301.56M

Downside

High risk

Typical loss in a bad month
37.6%
Volatility (annualized)
79%
Sharpe ratio, 1 year
0.51
Beta to the S&P 500 (5Y)
1.71

Typical bad-month loss, week by week

25%: high

Margins

Share of revenue, fiscal years 2011 to 2025

Gross margin

58.2%+1.0 pts over 5 years

Operating margin

20.4%−9.4 pts over 5 years

Net margin

17.4%−7.8 pts over 5 years

See a number that looks wrong?